$STSSW News

Last published 3mo ago

3mo agoSKYA STSSWSkyAI Reports Second Quarter 2026 Financial ResultsGlobeNewswireCompleted rebrand to SkyAI, reflecting the Company’s strategic evolution toward building an agentic finance platform on top of its Solana Digital Asset Treasury Appointed Arthur Levine as Chief Financial Officer,
5mo agoSKYA STSS STSSWSkyAI Appoints Veteran Finance Executive Arthur Levine as Chief Financial OfficerGlobeNewswireMission-critical appointment with extensive public company, multinational, and emerging growth experience as SkyAI advances its agentic finance platformMarks the latest step in the Company's evolution as it continues
5mo agoSKYA STSS STSSWSharps Technology Becomes SkyAI, Inc. with New Ticker Symbol "SKYA"; Establishing Category-defining Agentic Finance Platform Serving Global SouthGlobeNewswireRebrand to SkyAI, Inc. to reflect evolution of the business to build a global agentic finance platformOpened operational headquarters in Hong Kong, a global hub for financial technology innovation and a base for
7mo agoSTSS STSSWSharps Technology Reports 2025 Year-End Results and Highlights Continued Execution of Solana Treasury StrategyGlobeNewswireOver 2 Million SOL Held with Approximately 95% Staked at ~7% Gross Annualized YieldTotal Assets of $269.1 Million, Up from $7.3 Million at Year-End 2024Expanded Solana Ecosystem Partnerships Including Coinbase,
8mo agoSTSS STSSWSharps Technology and The Tie Announce Strategic Collaboration to Advance Institutional Participation in the Solana EcosystemGlobeNewswireNEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. ("STSS" or the "Company") (NASDAQ:STSS), a medical device company with a Solana digital asset treasury strategy, and The Tie, Inc. ("The Tie"), the
9mo agoBTGO STSS STSSWSharps Technology and BitGo Announce Collaboration to Advance Solana Treasury StrategyGlobeNewswireNEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. ("STSS" or the "Company") (NASDAQ:STSS), a medical device company with a Solana (SOL) digital asset treasury strategy, and BitGo Bank & Trust,
9mo agoSTSS STSSWSharps Technology Reports Strong Solana Staking IncomeGlobeNewswireNEW YORK, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. ("STSS" or the "Company"), a medical device company implementing a Solana-based digital asset treasury strategy, today issued an update on its
10mo agoSTSS STSSWSharps Technology Strengthens Market Confidence with Advisor Lock-Up AgreementGlobeNewswireNEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ:STSS) today announced that it has entered into a 90-day lock-up agreement with SOL Markets (the "Strategic Advisor"), pursuant to which SOL
10mo agoSTSS STSSWSharps Technology and Coinbase Expand Relationship with Launch of Institutional-Grade Solana ValidatorGlobeNewswireNEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. ("STSS" or the "Company") (NASDAQ:STSS), a medical device company implementing a Solana-based digital asset treasury strategy, today announced the
12mo agoSTSS STSSWSharps Technology Reports Strong Growth in Q3 2025 as it Advances Execution of Treasury StrategyGlobeNewswireNEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. ("STSS" or the "Company"), a U.S.-based medical device sales and distribution platform that has adopted a Solana-based treasury strategy, today
1y agoSTSS STSSWSharps Technology Advances Shipment Under $50 Million SoloGard Supply Agreement and Begins Manufacturing Facility UpgradesGlobeNewswireSecond commercial delivery underway as part of multi-year contract with leading U.S. healthcare partnerStrategic manufacturing upgrades drive scalability, efficiency, and increases capacity to support production growth
1y agoSTSS STSSWSharps Technology CEO, Robert Hayes, to Present at the Virtual Investor Summit on June 10, 2025GlobeNewswireNEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: "STSS" and "STSSW") ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart
1y agoSTSS STSSWSharps Technology Begins Shipments Across Three Customer Orders Under Previously Announced Purchase AgreementsGlobeNewswireShipments include initial deliveries of SecureGard™ and SoloGard™ smart safety syringes from its Hungary-based manufacturing facility Deliveries mark the Company's transition to a commercial-stage,
1y agoSTSS STSSWSharps Technology Regains Compliance with Nasdaq Minimum Bid Price Listing RuleGlobeNewswireNEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: "STSS" and "STSSW") ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class
1y agoSTSS STSSWSharps Technology to Present at the Aegis Capital Corp. 2025 Virtual Conference on May 22ndGlobeNewswireNEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: "STSS" and "STSSW") ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class
1y agoSTSS STSSWSharps Technology Receives ~$100K Initial Purchase Order from Hungarian Vaccine Provider for SecureGard™ SyringesGlobeNewswireSharps also received an initial qualification purchase order for DisGard™ single-use Sharps Recovery System Company transitions to revenue producing with second purchase order, bringing total recent orders
1y agoSTSS STSSWSharps Technology Secures $400K Initial Purchase Order from U.S. Leader in IV Flushing Solutions as Part of $50 Million SoloGard Supply AgreementGlobeNewswireMilestone order marks first commercial revenue for Sharps Technology under multi-year, 500-million syringe agreementInvestments in best-in-class manufacturing equipment position Sharps to offer differentiated high-volume
1y agoSTSS STSSWSharps Technology Announces Reverse Stock SplitGlobeNewswireNEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: "STSS" and "STSSW") ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class
1y agoSTSS STSSWSharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on March 28, 2025GlobeNewswireNEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ:STSS) (the "Company" or "Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe
1y agoSTSS STSSWSharps Technology's CEO Issues Corporate Update Highlighting Agreements for SecureGard and SoloGard and Revenue Developments from Manufacturing Operations in HungaryGlobeNewswireNEW YORK, March 06, 2025 (GLOBE NEWSWIRE) -- Dear Fellow Shareholders, As we reflect on the progress since our December update, I am excited to share the latest developments that will shape our Company's
1y agoSTSS STSSWSharps Technology, Inc. Announces Closing of Upsized $20.0 Million Underwritten Public OfferingGlobeNewswireNEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ:STSS) (the "Company"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products,
1y agoSTSS STSSWSharps Technology, Inc. Announces Pricing of Upsized $20.0 Million Underwritten Public OfferingGlobeNewswireNEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ:STSS) (the "Company"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products,
1y agoSTSS STSSWSharps Technology's CEO Issues Shareholder Letter Highlighting Hungary Manufacturing Facility Expansion Plans to Increase SecureGard and SoloGard Product Supply and RevenueGlobeNewswireShareholder letter includes details about the $50+ million sales agreement with a US-based pharma company, plans for Hungary SoloGard manufacturing expansion, and expected delivery scheduleInitial production and
1y agoSTSS STSSWSharps Technology Signs Sales Agreements to Support Major European Healthcare Network and Sells Out Its Inventory for SecureGardGlobeNewswireSigned multiple agreements to sell its SecureGard syringe inventory, with initial shipments and revenue commencing in early DecemberAgreements also include new forecasted orders and commitments for all current SecureGard
1y agoSTSS STSSWSharps Regains Nasdaq Listing ComplianceGlobeNewswireNEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: "STSS" and "STSSW") ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe
2y agoSTSS STSSWSharps Technology, Inc. Announces Stockholders' Approval of Reverse Stock Split Ratio and Effective DateGlobeNewswireNEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: "STSS" and "STSSW") ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class
2y agoSTSS STSSWSharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on October 7, 2024GlobeNewswireNEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ:STSS) (the "Company"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products,
2y agoSTSS STSSWSharps Technology, Inc. Closes $3.5 Million Bridge FinancingGlobeNewswireNEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ:STSS) (the "Company"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products,
2y agoSTSS STSSWSharps Technology, Inc. Announces $3.5 Million Bridge FinancingGlobeNewswireNEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ:STSS) (the "Company"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products,
2y agoSTSS STSSWSharps Technology Announces Continued Listing on Nasdaq Pending Results of an Upcoming Special Shareholders' MeetingGlobeNewswireNEW YORK, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ:STSS) ("Sharps Technology" or the "Company"), an innovative medical device and pharmaceutical packaging company offering patented,
2y agoSTSS STSSWSharps Technology Enters Into a Five-Year Sales Agreement with Strategic U.S. Medical Products Company Creating +$5O Million in New Revenue for EU FacilityGlobeNewswireDefinitive agreement sells out the 10mL SoloGard production capacity at Sharps' manufacturing site in the EU and drives expansion to support the project's growth in the future Sharps' portfolio of products provides
2y agoSTSS STSSWSharps Technology CEO Urges Shareholders to Vote in Support of the Three Proposals by the July 12 Voting DeadlineGlobeNewswireRobert Hayes issues a letter to shareholders asking their voting approval on three proposals vital to the Company's continued growth. Voting deadline is Friday, July 12, at 11:59 p.m. Eastern Time. NEW YORK,
2y agoSTSS STSSWSharps Technology Receives Purchase Orders for 1 Million SecureGard Syringes for 2024 DeliveryGlobeNewswireSwiss-based provider of cosmetic, dental, and ophthalmic injectable therapies issues purchase orders for 1mL SecureGard ultra-low waste, smart safety syringes First 100k unit shipment is scheduled for late July, with
2y agoSTSS STSSWSharps Technology Urges Shareholders to Approve the Proposals in connection with the Special Meeting on July 15, 2024GlobeNewswireAll shareholders of record as of May 17, 2024 are eligible to vote Final votes must be cast by 11:59 p.m., Eastern Time on July 12, 2024 NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc.
2y agoSTSS STSSWSharps Technology Ships First Orders for Securegard Disposable Smart Safety Syringes to Strategic Distribution Partner in ColombiaGlobeNewswireNEW YORK, June 17, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ: "STSS" and "STSSW"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products,
2y agoSTSS STSSWJoin Sharps Technology's Exclusive Live Investor Webinar and Q&A Session on June 18GlobeNewswireNEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ: "STSS" and "STSSW"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is
2y agoSTSS STSSWSharps Technology Receives $30 Million Purchase Order for Prefillable Copolymer Syringes to be Manufactured at SC FacilityGlobeNewswireSigned PO secures first 12 months of syringe product orders against Sharps and Nephron's five-year, $200 million Syringe Sales Agreement. Current Asset Purchase Agreement closing timeline is on track for expected
2y agoSTSS STSSWSharps Technology Secures SC Asset Purchase Exclusivity with $1 Million Escrow DepositGlobeNewswireInjectEZ acquisition establishing Sharps position in the prefillable syringe (PFS) industry in the U.S. has progressed with the payment of $1 million into third-party escrow account. Closing on the Asset Purchase and
2y agoSTSS STSSWSharps Technology's SC Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.GlobeNewswireSharps CEO issues letter to shareholders with details about the InjectEZ acquisition, establishing Sharps position in the prefillable syringe (PFS) industry in the U.S. Signed Syringe Sales Agreement will secure
2y agoSTSS STSSWSharps Technology Signs 5-Year, $200 Million Syringe Sales Agreement and Amendment to Asset Purchase Agreement to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.GlobeNewswireSharps will strengthen its manufacturing capacity with a $35 million acquisition of assets, establishing the Company's position in the specialized copolymer prefillable syringe (PFS) system industry in the U.S.
2y agoSTSS STSSWSharps Technology Positioned to Address Supply Chain Disruptions Resulting from Recent FDA Recalls, Warnings, and Tariffs on Chinese Manufactured SyringesGlobeNewswireSharps CEO issues letter to shareholders on FDA actions and tariffs affecting Chinese syringes. The FDA began raising quality concerns over Chinese-manufactured syringes in November 2023, resulting in multiple recalls
2y agoSTSS STSSWSharps Technology and Roncadelle Operations Sign Worldwide Sales and Distribution Agreement for their Innovative Portfolio of Safe Technology Drug Delivery SystemsGlobeNewswireNEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ: "STSS" and "STSSW"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products,
2y agoSTSS STSSWSharps Technology Enters Latin American Market and Receives First Orders for Securegard Disposable Smart Safety Syringes from Strategic Distribution Partner in ColombiaGlobeNewswireNEW YORK, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ: "STSS" and "STSSW"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is
2y agoSTSS STSSWSharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery SystemsGlobeNewswireNEW YORK, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ:STSS) (NASDAQ:STSSW), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is
2y agoSTSS STSSWSharps Technology Signs LOI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery SystemsGlobeNewswireNEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ: "STSS" and "STSSW"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products,
3y agoSTSS STSSWSharps Technology Announces Closing of $5.6 Million Registered Direct and Private PlacementGlobeNewswireNEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the "Company") (NASDAQ: "STSS" and "STSSW"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class
3y agoSTSS STSSWSharps Technology Issues Letter to Shareholders Covering the Announced Asset Purchase Agreement to Acquire InjectEZ Prefillable Syringe Manufacturing Facility and the Associated $400 Million 10-Year Purchase Agreement with Nephron PharmaceuticalsGlobeNewswireTransformative acquisition and purchase order enables Sharps to commercialize its innovative copolymer prefillable syringe systems to the healthcare market Company has a capitalization strategy through debt that has
3y agoSTSS STSSWUPDATE - Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq RulesGlobeNewswireNEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the "Company") (NASDAQ: "STSS" and "STSSW"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class
3y agoSTSS STSSWSharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq RulesGlobeNewswireNEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the "Company") (NASDAQ: "STSS" and "STSSW"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class
3y agoSTSS STSSWSharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility and a 10-Year Purchase Agreement for Over $400 Million from Nephron PharmaceuticalsGlobeNewswire$50 Million acquisition of InjectEZ strengthens manufacturing capacity and establishes Sharps' leading position in the specialized copolymer prefillable syringe system industry Signed term sheet providing for up